Brampton included in program that will give AstraZeneca-Oxford vaccine to those 60 to 64
Brampton will be part of a pilot project that will allow primary care providers such as pharmacies to administer the AstraZeneca-Oxford vaccine.
Details of the program are expected to be announced later today.
The project will be for those ages 60 to 64.
The AstraZeneca-Oxford vaccine was only just recently approved for use in Canada; however, Canadian health officials have determined that it will be less effective than other vaccines in battling COVID-19 for those over the age of 65.
Because the vaccine has already been purchased by Canada, it was decided to make it available to people between the ages of 60 and 64.
- Mississauga to be part of pilot project involving AstraZeneca-Oxford vaccine
- Ontario health minister will take Oxford-AstraZeneca vaccine to combat hesitancy
- Ontario pharmacy COVID-19 vaccine pilot to begin next week with Oxford-AstraZeneca
- Health Canada approves AstraZeneca’s COVID-19 vaccine
- National panel advises against using Oxford-AstraZeneca’s COVID-19 vaccine on seniors
- Brampton truck driver charged for smuggling cocaine into Canada
- Alarmingly 20% of all Brampton being tested currently have COVID-19
- Mississauga boxing gym defying provincial lockdown orders facing charges by City
- Gun play has police on the scene at Brampton neighbourhood
- Mississauga ticketing for gathering in parks to home hair salons and more